Lark Health Raises $55 Million Series C to Bring A.I.-Driven Chronic Conditions Care to More People
MOUNTAIN VIEW, Calif. (October 8, 2020) — Lark Health today announced it has closed a $55 million Series C funding round led by King River Capital, as well as a $15 million venture debt credit facility with Trinity Capital and Bridge Bank. The round also includes new investors Franklin Templeton, SteelSky Ventures, and Olive Tree Capital; and existing Lark investors Lightspeed Ventures, Asset Management Ventures, Dr. Jonathan Fielding of UCLA Fielding School of Public Health, and Weili Dai, co-founder of Marvell. Lark has raised a total of over $100 million in equity and debt funding to date.
Having managed nearly two million patients on its platform, Lark will use the funds to further expand its relationships with commercial payers and telehealth providers for chronic disease prevention and management. For example, Lark will expand its relationship with Anthem-affiliated health plans to power digital coaching through the health plans’ mobile app. In addition, Lark is now the Preferred Provider for its Diabetes Prevention Program to these Anthem-affiliated health plans. Lark’s DPP has received the highest level of clinical recognition – Full Recognition – from the Centers for Disease Control and Prevention.